ZENOBE GRAMME (ZEN.BR) Fundamental Analysis & Valuation

EBR:ZEN • BE0003809267

Current stock price

226 EUR
+6 (+2.73%)
Last:

This ZEN.BR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. ZEN.BR Profitability Analysis

1.1 Basic Checks

  • In the past year ZEN has reported negative net income.
ZEN.BR Yearly Net Income VS EBIT VS OCF VS FCFZEN.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2021 2023 2024 0 200K 400K 600K 800K 1M

1.2 Ratios

  • With a Return On Assets value of -0.11%, ZEN perfoms like the industry average, outperforming 44.78% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of -12.00%, ZEN is doing worse than 68.66% of the companies in the same industry.
  • ZEN's Return On Invested Capital of 12.15% is amongst the best of the industry. ZEN outperforms 97.01% of its industry peers.
Industry RankSector Rank
ROA -0.11%
ROE -12%
ROIC 12.15%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ZEN.BR Yearly ROA, ROE, ROICZEN.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2021 2023 2024 0 5 -5 10

1.3 Margins

  • The Operating Margin of ZEN (47.78%) is better than 74.63% of its industry peers.
  • In the last couple of years the Operating Margin of ZEN has declined.
  • The Profit Margin and Gross Margin are not available for ZEN so they could not be analyzed.
Industry RankSector Rank
OM 47.78%
PM (TTM) N/A
GM N/A
OM growth 3Y-3.97%
OM growth 5Y-3.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ZEN.BR Yearly Profit, Operating, Gross MarginsZEN.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2021 2023 2024 0 10 20 30 40 50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. ZEN.BR Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for ZEN remains at a similar level compared to 1 year ago.
  • ZEN has less shares outstanding than it did 5 years ago.
  • ZEN has a better debt/assets ratio than last year.
ZEN.BR Yearly Shares OutstandingZEN.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2021 2023 2024 20 40 60 80
ZEN.BR Yearly Total Debt VS Total AssetsZEN.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2021 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

  • Based on the Altman-Z score of 1.21, we must say that ZEN is in the distress zone and has some risk of bankruptcy.
  • ZEN has a better Altman-Z score (1.21) than 68.66% of its industry peers.
  • ZEN has a Debt/Equity ratio of 78.50. This is a high value indicating a heavy dependency on external financing.
  • With a Debt to Equity ratio value of 78.50, ZEN is not doing good in the industry: 80.60% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 78.5
Debt/FCF N/A
Altman-Z 1.21
ROIC/WACCN/A
WACCN/A
ZEN.BR Yearly LT Debt VS Equity VS FCFZEN.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2021 2023 2024 2M 4M 6M

2.3 Liquidity

  • ZEN has a Current Ratio of 0.27. This is a bad value and indicates that ZEN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • ZEN has a Current ratio of 0.27. This is amonst the worse of the industry: ZEN underperforms 82.09% of its industry peers.
  • A Quick Ratio of 0.27 indicates that ZEN may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.27, ZEN is not doing good in the industry: 74.63% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.27
Quick Ratio 0.27
ZEN.BR Yearly Current Assets VS Current LiabilitesZEN.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2021 2023 2024 500K 1M 1.5M 2M 2.5M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. ZEN.BR Growth Analysis

3.1 Past

  • The Revenue has been growing slightly by 0.43% in the past year.
  • The Revenue has been growing slightly by 2.07% on average over the past years.
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-0.91%
Revenue 1Y (TTM)0.43%
Revenue growth 3Y3.39%
Revenue growth 5Y2.07%
Sales Q2Q%1.67%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ZEN.BR Yearly Revenue VS EstimatesZEN.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2021 2023 2024 500K 1M 1.5M 2M

More info and screens

Find the best growth stocksShow best growing peers

0

4. ZEN.BR Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ZEN. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ZEN.BR Price Earnings VS Forward Price EarningsZEN.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ZEN.BR Per share dataZEN.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 -40 -60 -80

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. ZEN.BR Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 5.64%, ZEN is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 4.53, ZEN pays a better dividend. On top of this ZEN pays more dividend than 83.58% of the companies listed in the same industry.
  • ZEN's Dividend Yield is rather good when compared to the S&P500 average which is at 1.91.
Industry RankSector Rank
Dividend Yield 5.64%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DPN/A
EPS Next 2YN/A
EPS Next 3YN/A
ZEN.BR Yearly Income VS Free CF VS DividendZEN.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2021 2023 2024 0 2K -2K 4K -4K

More info and screens

Find the best dividend stocksShow peers with best dividend

ZEN.BR Fundamentals: All Metrics, Ratios and Statistics

ZENOBE GRAMME

EBR:ZEN (3/16/2026, 7:00:00 PM)

226

+6 (+2.73%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap13.56M
Revenue(TTM)2.15M
Net Income(TTM)-9.60K
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.64%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.3
P/FCF N/A
P/OCF N/A
P/B 193.71
P/tB 193.71
EV/EBITDA N/A
EPS(TTM)-95.41
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS35.88
BVpS1.17
TBVpS1.17
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.11%
ROE -12%
ROCE 16.2%
ROIC 12.15%
ROICexc 12.15%
ROICexgc 12.15%
OM 47.78%
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-5.25%
ROICexgc growth 5Y1.71%
ROICexc growth 3Y-5.25%
ROICexc growth 5Y1.71%
OM growth 3Y-3.97%
OM growth 5Y-3.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.24
Health
Industry RankSector Rank
Debt/Equity 78.5
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.27
Quick Ratio 0.27
Altman-Z 1.21
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-0.91%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.43%
Revenue growth 3Y3.39%
Revenue growth 5Y2.07%
Sales Q2Q%1.67%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-7.96%
EBIT growth 3Y-0.71%
EBIT growth 5Y-1.79%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

ZENOBE GRAMME / ZEN.BR Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ZENOBE GRAMME?

ChartMill assigns a fundamental rating of 2 / 10 to ZEN.BR.


What is the valuation status of ZENOBE GRAMME (ZEN.BR) stock?

ChartMill assigns a valuation rating of 0 / 10 to ZENOBE GRAMME (ZEN.BR). This can be considered as Overvalued.


Can you provide the profitability details for ZENOBE GRAMME?

ZENOBE GRAMME (ZEN.BR) has a profitability rating of 2 / 10.